Skip to main content
ImmuneCited

Processus de recherche

107 figures issues de recherches évaluées par des pairs

Tous Pelargonium sidoides Glutathione N-Acetylcysteine Astragalus Conjugated Linoleic Acid Curcumin Arginine Astaxanthin Cordyceps Omega-3 Fatty Acids (EPA/DHA) Zinc Quercetin Elderberry Resveratrol Vitamin D Andrographis Iron
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 3. Pictorial representation of Cordyceps therapeutic potential in general. Table 2. Nutraceutical products from Cordyceps available on the global market.
Figure 8

Cordyceps-derived products are available globally as nutraceutical supplements. This figure combines a pictorial representation of Cordyceps' therapeutic potential with a table of commercially available nutraceutical formulations.

Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic …

Figure 5
Figure 5

Tabular or graphical summary of animal model studies evaluating resveratrol's therapeutic effects on endometriotic lesion size, vascularization, and inflammatory marker expression.

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.

Figure 8
Figure 8

Comparison of resveratrol with conventional endometriosis therapies or other natural compounds, highlighting potential advantages of the polyphenolic approach.

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.

Figure 7
Figure 7

Characteristics of included studies on arginine supplementation for wound healing are summarized in tabular form. The table captures study design, participant demographics, dosage protocols, and primary outcome measures across the selected trials.

The Effect of Amino Acids on Wound Healing: A Systematic Review and …

Figure 9
Figure 9

Study characteristics for the glutamine supplementation arm of the systematic review are presented. The compilation enables cross-study comparison of dosing regimens, wound types, and healing outcomes measured in human trials.

The Effect of Amino Acids on Wound Healing: A Systematic Review and …

Figure 12
Figure 12

Supplementary characterization or additional in vivo data from the click chemistry hydrogel study is presented. The comprehensive evaluation supports the platform's potential for translational application in diabetic wound management.

A click chemistry-mediated all-peptide cell printing hydrogel platform for diabetic wound healing.

Figure 2
Figure 2

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 3
Figure 3

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 4
Figure 4

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 5
Figure 5

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 6
Figure 6

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 7
Figure 7

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

Figure 8
Figure 8

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by …

FIGURE 1—A schematic of the prospective cohort study (study 1) that investigated the association between vitamin D status (serum 25(OH)D), URTI and days lost from training, and the randomized controlled trial (study 2) that investigated the effects of vit
Figure 2

FIGURE 1—A schematic of the prospective cohort study (study 1) that investigated the association between vitamin D status (serum 25(OH)D), URTI and days lost from training, and the randomized controlled …

Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on …

FIGURE 2—Seasonal variation in serum 25(OH)D (A), vitamin D sufficiency prevalence (serum 25(OH)D ≥50 nmol·L−1; B), and the URTI prevalence when serum 25(OH)D ≥50 nmol·L 1 or <50 nmol·L 1 (C) in 1644 men and women during 12 wk of military training. aLo
Figure 3

FIGURE 2—Seasonal variation in serum 25(OH)D (A), vitamin D sufficiency prevalence (serum 25(OH)D ≥50 nmol·L−1; B), and the URTI prevalence when serum 25(OH)D ≥50 nmol·L 1 or <50 nmol·L 1 …

Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on …

FIGURE 3—Flow diagram of the randomized controlled trial (study 2) investigating the effects of vitamin D supplementation on URTI and mucosal immunity. Flow diagram indicates the number of participants assessed, randomized to solar simulated radiation (SS
Figure 4

FIGURE 3—Flow diagram of the randomized controlled trial (study 2) investigating the effects of vitamin D supplementation on URTI and mucosal immunity. Flow diagram indicates the number of participants assessed, …

Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on …

FIGURE 4—Serum 25(OH)D in men completing military training while receiving 12 wk of vitamin D supplementation (solar simulated radiation [SSR] or oral vitamin D3 [ORAL]) or a placebo (solar simulated radiation placebo [SSR-P] or oral placebo [ORAL-P]). Co
Figure 5

FIGURE 4—Serum 25(OH)D in men completing military training while receiving 12 wk of vitamin D supplementation (solar simulated radiation [SSR] or oral vitamin D3 [ORAL]) or a placebo (solar simulated …

Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on …

FIGURE 5—URTI average duration (A and D), peak URTI severity (B and E), and total days with URTI during military training (C and F), in the vitamin D supplementation (SSR and ORAL) vs placebo supplementation groups (SSR-P and ORAL-P) in all participants (
Figure 6

FIGURE 5—URTI average duration (A and D), peak URTI severity (B and E), and total days with URTI during military training (C and F), in the vitamin D supplementation (SSR …

Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on …

Figure 1
Figure 1

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 2
Figure 2

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 3
Figure 3

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 4
Figure 4

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 5
Figure 5

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Figure 6
Figure 6

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway …

Page 1 sur 5